Micronutrient and Additive Modifications May Optimize Diet To Health

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRegion Skane

About this trial

This is a prospective clinical intervention trial where patients with moderately active ulcerative colitis are randomized to either normal healthy diet or a diet with elimination of emulsifying agents within the E 400-group with special respect to carragenan, CMC and polysorbates. At study start and end after one month their diet, clinical characteristics and microbiota will be analysed. The hypotheses are that their disease activity measured with calprotectin and their microbiota will improve after intervention.

Eligibility criteria

Qualifiers

Ulcerative colitis,

Moderately active

Stable medication

Disqualifiers

Severe disease

Recent surgery

Proctitis

Pregancy

Trial design

Treatments tested in this trial

  • Normal diet
  • E400 elimination

Treatment groups

70 Participants
are divided into 2 treatment groups

Sponsors and collaborators